Operating Margin - Cartesian Therapeutics Inc (NASDAQ:RNAC) - Alpha Spread

Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 16.54 USD 5.82% Market Closed
Market Cap: 353.6m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

Operating Margin
Cartesian Therapeutics Inc

-90.6%
Current
-80%
Average
-8.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-90.6%
=
Operating Profit
-49m
/
Revenue
54.1m

Operating Margin Across Competitors

Country US
Market Cap 353.6m USD
Operating Margin
-91%
Country US
Market Cap 341.9B USD
Operating Margin
29%
Country US
Market Cap 180.5B USD
Operating Margin
20%
Country US
Market Cap 129B USD
Operating Margin
31%
Country US
Market Cap 123.6B USD
Operating Margin
41%
Country US
Market Cap 104.5B USD
Operating Margin
37%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 142.3B AUD
Operating Margin
26%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country US
Market Cap 38.5B USD
Operating Margin
-555%
Country US
Market Cap 35.4B USD
Operating Margin
4%

Profitability Report

View the profitability report to see the full profitability analysis for Cartesian Therapeutics Inc.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-90.6%
=
Operating Profit
-49m
/
Revenue
54.1m
What is the Operating Margin of Cartesian Therapeutics Inc?

Based on Cartesian Therapeutics Inc's most recent financial statements, the company has Operating Margin of -90.6%.